SG Americas Securities LLC Invests $691,000 in Perrigo Company plc (NYSE:PRGO)

SG Americas Securities LLC purchased a new position in shares of Perrigo Company plc (NYSE:PRGO - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 26,868 shares of the company's stock, valued at approximately $691,000.

Several other hedge funds have also made changes to their positions in PRGO. Versant Capital Management Inc purchased a new stake in Perrigo during the 4th quarter worth approximately $45,000. GAMMA Investing LLC increased its position in shares of Perrigo by 93.7% during the fourth quarter. GAMMA Investing LLC now owns 1,920 shares of the company's stock worth $49,000 after acquiring an additional 929 shares during the period. Central Pacific Bank Trust Division raised its stake in shares of Perrigo by 33.3% in the fourth quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company's stock valued at $51,000 after acquiring an additional 500 shares in the last quarter. Venturi Wealth Management LLC acquired a new stake in shares of Perrigo in the third quarter valued at $56,000. Finally, KBC Group NV grew its stake in Perrigo by 25.1% during the 3rd quarter. KBC Group NV now owns 4,517 shares of the company's stock worth $118,000 after purchasing an additional 905 shares in the last quarter. Institutional investors and hedge funds own 95.91% of the company's stock.

Insider Transactions at Perrigo

In other news, Director Jeffrey B. Kindler sold 17,598 shares of Perrigo stock in a transaction on Monday, December 9th. The shares were sold at an average price of $28.27, for a total value of $497,495.46. Following the transaction, the director now directly owns 5,409 shares of the company's stock, valued at $152,912.43. The trade was a 76.49 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 0.70% of the company's stock.

Perrigo Stock Up 0.8 %

PRGO traded up $0.20 on Monday, reaching $25.11. The company's stock had a trading volume of 1,037,598 shares, compared to its average volume of 1,349,777. The company has a market capitalization of $3.43 billion, a price-to-earnings ratio of -21.46 and a beta of 0.53. Perrigo Company plc has a fifty-two week low of $23.14 and a fifty-two week high of $33.46. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94. The stock has a 50 day moving average of $26.01 and a two-hundred day moving average of $26.58.

Perrigo (NYSE:PRGO - Get Free Report) last issued its earnings results on Wednesday, November 6th. The company reported $0.81 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.81. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The business had revenue of $1.09 billion during the quarter, compared to analysts' expectations of $1.12 billion. During the same quarter in the prior year, the business posted $0.64 EPS. The company's revenue for the quarter was down 3.2% on a year-over-year basis. As a group, analysts forecast that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently commented on PRGO shares. Piper Sandler downgraded Perrigo from an "overweight" rating to a "neutral" rating and lowered their price objective for the stock from $34.00 to $27.00 in a research report on Monday, January 6th. StockNews.com cut shares of Perrigo from a "buy" rating to a "hold" rating in a report on Saturday, January 11th. Finally, Argus lowered shares of Perrigo from a "buy" rating to a "hold" rating in a report on Tuesday, January 14th. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Perrigo presently has an average rating of "Hold" and an average price target of $35.00.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.